Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Bristol-Myers Squibb Company BMY |
BLACKROCK INC BLK |
143,574,230 7.100% |
-24,523,997 (-14.59%) |
Filing History |
| 2025-02-14 4:10 pm Sale |
2024-12-31 | 13G | Celularity Inc. CELU |
BRISTOL MYERS SQUIBB CO BMY |
426,372 1.900% |
-768,955 (-64.33%) |
Filing History |
| 2025-02-14 4:10 pm Sale |
2024-12-31 | 13G | Compugen Ltd. CGEN |
BRISTOL MYERS SQUIBB CO BMY |
1,840,136 2.060% |
-2,916,922 (-61.32%) |
Filing History |
| 2025-02-14 4:10 pm Sale |
2024-12-31 | 13G | Q32 Bio Inc. QTTB |
BRISTOL MYERS SQUIBB CO BMY |
200,244 1.640% |
-558,901 (-73.62%) |
Filing History |
| 2024-11-13 4:05 pm Unchanged |
2024-09-30 | 13G | Avidity Biosciences, Inc. RNA |
BRISTOL MYERS SQUIBB CO BMY |
5,075,304 4.300% |
0 (Unchanged) |
Filing History |
| 2024-11-13 4:05 pm Unchanged |
2024-09-30 | 13G | uniQure N.V. QURE |
BRISTOL MYERS SQUIBB CO BMY |
2,388,108 4.900% |
0 (Unchanged) |
Filing History |
| 2024-11-13 4:05 pm Unchanged |
2024-09-30 | 13G | Ikena Oncology, Inc. IKNA |
BRISTOL MYERS SQUIBB CO BMY |
2,133,142 4.400% |
0 (Unchanged) |
Filing History |
| 2024-11-13 4:05 pm Purchase |
2024-03-25 | 13G | Q32 Bio Inc. QTTB |
BRISTOL MYERS SQUIBB CO BMY |
759,145 6.230% |
759,145 (New Position) |
Filing History |
| 2024-10-04 4:20 pm Purchase |
2023-09-30 | 13G | Prime Medicine, Inc. PRME |
BRISTOL MYERS SQUIBB CO BMY |
11,006,163 8.400% |
11,006,163 (New Position) |
Filing History |
| 2024-02-13 5:00 pm Sale |
2023-12-29 | 13G | Bristol-Myers Squibb Company BMY |
The Vanguard Group | 198,155,594 9.740% |
-4,772,026 (-2.35%) |
Filing History |
| 2024-01-25 4:59 pm Sale |
2023-12-31 | 13G | Bristol-Myers Squibb Company BMY |
BLACKROCK INC BLK |
168,098,227 8.300% |
-4,622,150 (-2.68%) |
Filing History |
| 2023-12-04 4:13 pm Purchase |
2023-11-27 | 13G | Avidity Biosciences, Inc. RNA |
BRISTOL MYERS SQUIBB CO BMY |
5,075,304 6.400% |
5,075,304 (New Position) |
Filing History |
| 2023-02-09 11:12 am Purchase |
2022-12-30 | 13G | Bristol-Myers Squibb Company BMY |
The Vanguard Group | 202,927,620 9.540% |
3,093,137 (+1.55%) |
Filing History |
| 2023-02-07 2:10 pm Purchase |
2022-12-31 | 13G | Bristol-Myers Squibb Company BMY |
BLACKROCK INC BLK |
172,720,377 8.100% |
3,493,671 (+2.06%) |
Filing History |
| 2022-02-09 3:33 pm Purchase |
2021-12-31 | 13G | Bristol-Myers Squibb Company BMY |
The Vanguard Group | 199,834,483 9.000% |
494,025 (+0.25%) |
Filing History |
| 2022-01-31 5:59 pm Sale |
2021-12-31 | 13G | Bristol-Myers Squibb Company BMY |
BLACKROCK INC BLK |
169,226,706 7.600% |
-3,238,098 (-1.88%) |
Filing History |
| 2021-11-19 4:15 pm Purchase |
2021-11-10 | 13G | Compugen Ltd. CGEN |
BRISTOL MYERS SQUIBB CO BMY |
4,757,058 5.500% |
4,757,058 (New Position) |
Filing History |
| 2021-07-26 5:10 pm Purchase |
2021-07-16 | 13G | Celularity Inc. CELU |
BRISTOL MYERS SQUIBB CO BMY |
1,195,327 9.900% |
1,195,327 (New Position) |
Filing History |
| 2021-04-05 5:28 pm Purchase |
2020-12-31 | 13G | Sutro Biopharma, Inc. STRO |
BRISTOL MYERS SQUIBB CO BMY |
1,726,197 3.800% |
1,726,197 (New Position) |
Filing History |
| 2021-04-05 5:27 pm Purchase |
2019-11-20 | 13G | IDEAYA Biosciences, Inc. IDYA |
BRISTOL MYERS SQUIBB CO BMY |
1,633,254 5.100% |
1,633,254 (New Position) |
Filing History |